Medical Device News Magazine

iApotheca Healthcare Inc. Announces Closing of $470K Angel Funding Round

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

iApotheca Healthcare, the developers of a leading Canadian pharmacy software operations platform, has announced the closing of a $470k angel funding round. iApotheca will use the funds to accelerate their EconoRoute™ Prescription Delivery System through the addition of key team members, ongoing platform development and the expansion of the EconoRoute™ network.

“Prescription delivery is revolutionizing the way people interact with their chosen pharmacy,” said Spencer Turbitt, co-founder and CEO of iApotheca. “We would like to thank Leva Capital, York Angels, and Valhalla Angels for their investment in our company. Their investment and advice are allowing us to accelerate our plans to achieve our vision for the pharmacy delivery space.”

iApotheca specializes in streamlining pharmacy operations, particularly in prescription delivery service, to help pharmacies grow their revenue. In recent years, the demand for prescription delivery has seen a sharp rise. iApotheca’s EconoRoute™ prescription delivery software supports the demand with an easy-to-use, low-cost, one-stop solution for pharmacies of all sizes.

“Leva Capital is thrilled to announce the addition of iApotheca into our investment portfolio,” said Eddie Gobran, Managing Partner. “Their strategy aligns with our vision of investing in health technology that will improve the healthcare experience for Canadians. We are confident in iApotheca’s team to execute their strategy and deliver a great experience to pharmacies across Canada.”

EconoRoute™ includes features that make it an ideal delivery solution for any business. Its unique physics-based instant routing and real-time driver tracking are high-performance tools. Built-in pay-at-the-door functionality also makes it easy for businesses to track accounting.

iApotheca’s years of expertise in supporting pharmacies in doing business more efficiently make EconoRoute™ more than just another prescription delivery service.  The software has the added benefit of built-in compliance tools, cold-chain prioritization, and inherent patient privacy measures, all crucial for compliance. Taken together, these tools make EconoRoute™ a must-have for prescription delivery.

“Willowgrove Pharmacy has been using EconoRoute™ since its inception. After spending much time researching delivery platforms, EconoRoute™ came out the clear winner,” said Devon Elias, owner of Willowgrove Pharmacy in Manitoba. “The application does everything we need it to do. Optimization of routes, easy set up of regular repeat deliveries, tracking and signature requirements are all in one application, allowing for a single program to be our delivery central. Willowgrove Pharmacy employs three full-time positions for delivery of product and services and EconoRoute™ easily organizes it all.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”